首页 > 最新文献

Wiley最新文献

英文 中文
IF:
Dual Transcriptional Circuits: G1-OsMADS34 and G1-TGW2 Cooperatively Regulate Sterile Lemma Identity and Grain Size in Rice. 双转录回路:G1-OsMADS34和G1-TGW2协同调控水稻不育外稃身份和籽粒大小
IF 6.3 1区 生物学 Q1 PLANT SCIENCES Pub Date : 2026-04-01 Epub Date: 2026-01-04 DOI: 10.1111/pce.70364
Xuemei Qin, Ping Gan, Jinliang Sun, Di Wu, Ru Li, Tianmin Ouyang, Kaichong Teng, Weijian Cen, Baoxiang Qin, Fang Liu, Rongbai Li, Jijing Luo

Rice (Oryza sativa L.) features a unique inflorescence organ known as the spikelet, comprising floret, lemma/palea, sterile lemmas, and rudimentary glumes, of which the molecular regulation underlying sterile lemma identity remains elusive. Here, we isolated the G1 locus for sterile lemma specification using an F2 population developed by crossing between Nipponbare and LG7, a variety with a lemma-like-sterile lemma (lsl). An SNP (+323 G/A) in G1 alleles causes a serine to asparagine (S108N) substitution, leading to the lsl phenotype. Mechanistically, we found that G1 transactivates the expressions of both OsMADS34 and TGW2, two genes known to regulate sterile lemma identity and grain size, through binding to the YACTGTW and CArG-box motifs within their promoters, respectively. Subsequently, we reveal that the transactivation activity of G1NIP (allele from Nipponbare) is further enhanced through interactions with either OsMADS34 or TGW2. Furthermore, we demonstrated that G1 specifies sterile lemma identity via OsMADS34 and controls grain size through TGW2. Our results reveal two transcriptional circuits (G1-OsMADS34 and G1-TGW2) that are crucial for determining sterile lemma identity and grain size of rice, providing insights into genetic improvement for breeding programs.

水稻(Oryza sativa L.)有一个独特的花序器官,称为小穗,包括小花、外稃/稃、不育外稃和初级颖片,其中不育外稃同一性的分子调控尚不明确。在这里,我们利用Nipponbare和LG7(一个具有外稃样不育外稃(lsl)的品种)杂交而成的F2群体分离出G1位点用于不育外稃的鉴定。G1等位基因的一个SNP (+323 G/A)导致丝氨酸到天冬酰胺(S108N)的替换,导致lsl表型。在机制上,我们发现G1通过分别与启动子内的YACTGTW和CArG-box基序结合,激活OsMADS34和TGW2的表达,这两个基因已知调节不育外稃的特性和晶粒大小。随后,我们发现G1NIP(来自Nipponbare的等位基因)的转激活活性通过与OsMADS34或TGW2的相互作用进一步增强。此外,我们证明G1通过OsMADS34指定不育外稃身份,并通过TGW2控制晶粒大小。我们的研究结果揭示了两个转录回路(G1-OsMADS34和G1-TGW2)是决定水稻不育外稃身份和晶粒大小的关键,为育种计划的遗传改良提供了见解。
{"title":"Dual Transcriptional Circuits: G1-OsMADS34 and G1-TGW2 Cooperatively Regulate Sterile Lemma Identity and Grain Size in Rice.","authors":"Xuemei Qin, Ping Gan, Jinliang Sun, Di Wu, Ru Li, Tianmin Ouyang, Kaichong Teng, Weijian Cen, Baoxiang Qin, Fang Liu, Rongbai Li, Jijing Luo","doi":"10.1111/pce.70364","DOIUrl":"10.1111/pce.70364","url":null,"abstract":"<p><p>Rice (Oryza sativa L.) features a unique inflorescence organ known as the spikelet, comprising floret, lemma/palea, sterile lemmas, and rudimentary glumes, of which the molecular regulation underlying sterile lemma identity remains elusive. Here, we isolated the G1 locus for sterile lemma specification using an F<sub>2</sub> population developed by crossing between Nipponbare and LG7, a variety with a lemma-like-sterile lemma (lsl). An SNP (+323 G/A) in G1 alleles causes a serine to asparagine (S108N) substitution, leading to the lsl phenotype. Mechanistically, we found that G1 transactivates the expressions of both OsMADS34 and TGW2, two genes known to regulate sterile lemma identity and grain size, through binding to the YACTGTW and CArG-box motifs within their promoters, respectively. Subsequently, we reveal that the transactivation activity of G1<sup>NIP</sup> (allele from Nipponbare) is further enhanced through interactions with either OsMADS34 or TGW2. Furthermore, we demonstrated that G1 specifies sterile lemma identity via OsMADS34 and controls grain size through TGW2. Our results reveal two transcriptional circuits (G1-OsMADS34 and G1-TGW2) that are crucial for determining sterile lemma identity and grain size of rice, providing insights into genetic improvement for breeding programs.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"2008-2023"},"PeriodicalIF":6.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Hydrosulphide Ion Channel in Arabidopsis. 拟南芥氢硫化物离子通道的鉴定。
IF 6.3 1区 生物学 Q1 PLANT SCIENCES Pub Date : 2026-04-01 Epub Date: 2026-01-12 DOI: 10.1111/pce.70349
Wenze Zhang, Yue Guo, Tiantian Wu, Xiaoxue Ye, Panpan Li, Qi Jia, Yanxi Pei, Ben Zhang, Zhuping Jin
{"title":"Identification of Hydrosulphide Ion Channel in Arabidopsis.","authors":"Wenze Zhang, Yue Guo, Tiantian Wu, Xiaoxue Ye, Panpan Li, Qi Jia, Yanxi Pei, Ben Zhang, Zhuping Jin","doi":"10.1111/pce.70349","DOIUrl":"10.1111/pce.70349","url":null,"abstract":"","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"2221-2224"},"PeriodicalIF":6.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manipulating the Plastidial Glucose 6-Phosphate:Phosphate Co-Translocator 2 : A Novel Strategy to Modulate Lignin Downregulation. 调控Plastidial Glucose 6-Phosphate:Phosphate Co-Translocator 2:一种调节木质素下调的新策略。
IF 6.3 1区 生物学 Q1 PLANT SCIENCES Pub Date : 2026-04-01 Epub Date: 2026-01-14 DOI: 10.1111/pce.70391
Peipei Zhang, Yan Zhang, Liang Zhang
{"title":"Manipulating the Plastidial Glucose 6-Phosphate:Phosphate Co-Translocator 2 : A Novel Strategy to Modulate Lignin Downregulation.","authors":"Peipei Zhang, Yan Zhang, Liang Zhang","doi":"10.1111/pce.70391","DOIUrl":"10.1111/pce.70391","url":null,"abstract":"","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"2292-2294"},"PeriodicalIF":6.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Soluble urokinase plasminogen activator receptor and interleukin-6 improve prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes". 对“可溶性尿激酶纤溶酶原激活物受体和白介素-6改善1型糖尿病全因死亡率和主要不良心血管事件的预测”的更正。
IF 9.2 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2026-01-14 DOI: 10.1111/joim.70065
{"title":"Correction to \"Soluble urokinase plasminogen activator receptor and interleukin-6 improve prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes\".","authors":"","doi":"10.1111/joim.70065","DOIUrl":"10.1111/joim.70065","url":null,"abstract":"","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":" ","pages":"534-536"},"PeriodicalIF":9.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of hepatic steatosis and increased liver stiffness in Chinese children and adolescents: A national multicenter study. 中国儿童和青少年肝脂肪变性和肝硬化的患病率:一项全国性多中心研究。
IF 9.2 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2026-02-11 DOI: 10.1111/joim.70069
Xiaolin Ye, Xiaoguo Li, Zhenhua Zhao, Wenhui Li, Yiling Li, Feng Xie, Xiaosong Yan, Sumin Sui, Bohao Jin, Hua Zheng, Yu Ni, Yangzhen Bianba, Qu Ci, Yiwu Cheng, Fang Zhou, Lin Guan, Xinhe Zhang, Jie Wu, Xin Ni, Xiaolong Qi
{"title":"Prevalence of hepatic steatosis and increased liver stiffness in Chinese children and adolescents: A national multicenter study.","authors":"Xiaolin Ye, Xiaoguo Li, Zhenhua Zhao, Wenhui Li, Yiling Li, Feng Xie, Xiaosong Yan, Sumin Sui, Bohao Jin, Hua Zheng, Yu Ni, Yangzhen Bianba, Qu Ci, Yiwu Cheng, Fang Zhou, Lin Guan, Xinhe Zhang, Jie Wu, Xin Ni, Xiaolong Qi","doi":"10.1111/joim.70069","DOIUrl":"10.1111/joim.70069","url":null,"abstract":"","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":" ","pages":"529-533"},"PeriodicalIF":9.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. 瑞典代谢功能障碍相关脂肪变性肝病的患病率和危险因素:来自SCAPIS队列的见解
IF 9.2 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2026-02-05 DOI: 10.1111/joim.70071
Oumarou Nabi, Jonas Spaak, Göran Bergström, Gunnar Engström, Carl Johan Östgren, Andrei Malinovschi, Joel Kullberg, Anders Blomberg, Tomas Jernberg, Daniel P Andersson, Hannes Hagström

Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population cohort.

Methods: From the Swedish CArdioPulmonary bioImage Study (SCAPIS) cohort, we analyzed 27,763 participants aged 50-64 years who underwent extensive clinical characterization. MASLD was defined as <48 HU on non-contrast liver computed tomography (CT) imaging. The risk for advanced fibrosis was assessed using the dynamic aspartate aminotransferase (AST)/alanine transaminase (ALT) ratio.

Results: MASLD was present in 18.1% of participants and was more common in men than women (25.5% vs. 11.2%). Prevalence increased with cardiometabolic burden: from 7.0% among those without obesity, hypertension, or Type 2 diabetes mellitus (T2DM) to 70.2% among those with all three conditions. MASLD risk was elevated in individuals with obesity alone (adjusted odds ratio [aOR] 5.56; 95% CI = 4.89-6.31), T2DM alone (aOR = 2.66; 95% CI = 2.13-3.33), or hypertension alone (aOR = 1.78; 95% CI = 1.59-1.99). The combination of all three conferred the highest risk (aOR = 17.1; 95% CI = 14.0-20.9). Among persons with MASLD, 24.8% were classified as at risk for advanced fibrosis. Fibrosis risk was independently associated with hypertension (aOR = 1.44; 95% CI = 1.24-1.66), T2DM (aOR = 1.24; 95% CI = 1.06-1.46), male sex (aOR = 1.20; 95% CI = 1.02-1.42), and alcohol consumption (aOR per gram/day = 1.02; 95% CI = 1.01-1.03).

Conclusions: In Sweden, almost one in five middle-aged adults is affected by MASLD, with a quarter of cases at risk of advanced fibrosis. Male sex, obesity, T2DM, and hypertension are important predictors of the prevalence and severity of MASLD.

背景和目的:代谢功能障碍相关脂肪变性肝病(MASLD)是全球最常见的慢性肝病,但其患病率和严重程度在普通人群中仍不清楚。我们的目的是在一个大型瑞典普通人群队列中估计MASLD的患病率和晚期纤维化的风险。方法:来自瑞典心肺生物图像研究(SCAPIS)队列,我们分析了27,763名年龄在50-64岁的参与者,他们接受了广泛的临床特征。结果:18.1%的参与者存在MASLD,男性比女性更常见(25.5%比11.2%)。患病率随着心脏代谢负担的增加而增加:在没有肥胖、高血压或2型糖尿病(T2DM)的人群中,患病率从7.0%上升到所有三种情况的人群中的70.2%。单独肥胖(校正优势比[aOR] 5.56; 95% CI = 4.89-6.31)、单独T2DM (aOR = 2.66; 95% CI = 2.13-3.33)或单独高血压(aOR = 1.78; 95% CI = 1.59-1.99)患者的MASLD风险升高。三者联合使用的风险最高(aOR = 17.1; 95% CI = 14.0-20.9)。在MASLD患者中,24.8%被归类为晚期纤维化风险。纤维化风险与高血压(aOR = 1.44, 95% CI = 1.24-1.66)、T2DM (aOR = 1.24, 95% CI = 1.06-1.46)、男性(aOR = 1.20, 95% CI = 1.02-1.42)和饮酒(aOR / g /day = 1.02, 95% CI = 1.01-1.03)独立相关。结论:在瑞典,几乎五分之一的中年人受到MASLD的影响,其中四分之一的病例有晚期纤维化的风险。男性、肥胖、2型糖尿病和高血压是MASLD患病率和严重程度的重要预测因素。
{"title":"Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort.","authors":"Oumarou Nabi, Jonas Spaak, Göran Bergström, Gunnar Engström, Carl Johan Östgren, Andrei Malinovschi, Joel Kullberg, Anders Blomberg, Tomas Jernberg, Daniel P Andersson, Hannes Hagström","doi":"10.1111/joim.70071","DOIUrl":"10.1111/joim.70071","url":null,"abstract":"<p><strong>Background and aims: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population cohort.</p><p><strong>Methods: </strong>From the Swedish CArdioPulmonary bioImage Study (SCAPIS) cohort, we analyzed 27,763 participants aged 50-64 years who underwent extensive clinical characterization. MASLD was defined as <48 HU on non-contrast liver computed tomography (CT) imaging. The risk for advanced fibrosis was assessed using the dynamic aspartate aminotransferase (AST)/alanine transaminase (ALT) ratio.</p><p><strong>Results: </strong>MASLD was present in 18.1% of participants and was more common in men than women (25.5% vs. 11.2%). Prevalence increased with cardiometabolic burden: from 7.0% among those without obesity, hypertension, or Type 2 diabetes mellitus (T2DM) to 70.2% among those with all three conditions. MASLD risk was elevated in individuals with obesity alone (adjusted odds ratio [aOR] 5.56; 95% CI = 4.89-6.31), T2DM alone (aOR = 2.66; 95% CI = 2.13-3.33), or hypertension alone (aOR = 1.78; 95% CI = 1.59-1.99). The combination of all three conferred the highest risk (aOR = 17.1; 95% CI = 14.0-20.9). Among persons with MASLD, 24.8% were classified as at risk for advanced fibrosis. Fibrosis risk was independently associated with hypertension (aOR = 1.44; 95% CI = 1.24-1.66), T2DM (aOR = 1.24; 95% CI = 1.06-1.46), male sex (aOR = 1.20; 95% CI = 1.02-1.42), and alcohol consumption (aOR per gram/day = 1.02; 95% CI = 1.01-1.03).</p><p><strong>Conclusions: </strong>In Sweden, almost one in five middle-aged adults is affected by MASLD, with a quarter of cases at risk of advanced fibrosis. Male sex, obesity, T2DM, and hypertension are important predictors of the prevalence and severity of MASLD.</p>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":" ","pages":"481-501"},"PeriodicalIF":9.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12950636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146122923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug use among people in prison: A global review of epidemiology, harms and interventions. 监狱中人员吸毒:流行病学、危害和干预措施的全球审查。
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2026-04-01 Epub Date: 2025-11-20 DOI: 10.1111/add.70245
Louis Favril, John Strang, Seena Fazel

Background and aims: People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.

Methods: In this structured review, we searched PubMed and Web of Science for articles published between 2015 and August 2025. Systematic reviews, meta-analyses and large primary studies with unselected samples were given preference for inclusion.

Results: Four in ten adults who enter prison meet diagnostic criteria for a drug use disorder, a treatable psychiatric condition often underlying the offences that led to their incarceration. Drug use disorders are approximately ten times more prevalent among people in prison compared with the general population, with a higher excess in women. Comorbid mental disorders are common. Around a third of incarcerated individuals report using drugs during imprisonment, which poses a health and safety risk for people both living and working in prisons. Injecting drug use in prison contributes to blood-borne virus transmission. In addition to its strong link with recidivism, drug use is associated with a markedly increased risk of premature mortality after release from prison, particularly from drug-related causes within the first two weeks post-release. Despite robust evidence supporting the effectiveness of prison-based pharmacological (e.g. opioid agonist treatment) and psychosocial (e.g. therapeutic communities) interventions in reducing drug-related harms, there remains a significant treatment gap within prison settings worldwide. Further research is needed to assess the health benefits of harm reduction services in prisons, including needle and syringe programmes. Strategies to facilitate linkage to and retention in post-release services are key to ensure continuity of care and achieve sustainable treatment outcomes.

Conclusion: The high prevalence of drug use and its multiple adverse outcomes among people in prison underscore the need for provision of evidence-based interventions. Expanding and integrating prison-based and post-release interventions to address drug use has the potential to yield both public health and criminal justice benefits.

背景和目的:在刑事司法系统中,吸毒者的比例过高。我们的目的是对全球被监禁成年人中与药物使用和药物使用障碍有关的流行病学、危害和干预措施进行广泛的综合,并强调证据和实践方面的差距。方法:在这篇结构化综述中,我们检索了PubMed和Web of Science在2015年至2025年8月之间发表的文章。系统评价、荟萃分析和未选择样本的大型初步研究优先纳入。结果:十分之四进入监狱的成年人符合药物使用障碍的诊断标准,这是一种可治疗的精神疾病,通常是导致他们入狱的犯罪行为的基础。与一般人群相比,监狱服刑人员中药物使用障碍的发生率大约高出10倍,其中妇女的比例更高。共病性精神障碍很常见。大约三分之一的被监禁者报告在监禁期间吸毒,这对在监狱生活和工作的人构成健康和安全风险。在监狱中注射毒品有助于血液传播的病毒传播。除了与再犯密切相关外,吸毒还与出狱后过早死亡的风险显著增加有关,特别是在出狱后的头两周内因与毒品有关的原因过早死亡。尽管强有力的证据支持基于监狱的药理学(如阿片类激动剂治疗)和社会心理(如治疗社区)干预措施在减少毒品相关危害方面的有效性,但在世界各地的监狱环境中仍然存在重大的治疗差距。需要进一步研究,以评估监狱减少伤害服务,包括针头和注射器方案对健康的益处。促进与释放后服务的联系和保留的战略是确保护理连续性和实现可持续治疗成果的关键。结论:监狱中吸毒的高流行率及其多种不良后果强调了提供循证干预措施的必要性。扩大和整合基于监狱和释放后的干预措施,以解决吸毒问题,有可能带来公共卫生和刑事司法方面的惠益。
{"title":"Drug use among people in prison: A global review of epidemiology, harms and interventions.","authors":"Louis Favril, John Strang, Seena Fazel","doi":"10.1111/add.70245","DOIUrl":"10.1111/add.70245","url":null,"abstract":"<p><strong>Background and aims: </strong>People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.</p><p><strong>Methods: </strong>In this structured review, we searched PubMed and Web of Science for articles published between 2015 and August 2025. Systematic reviews, meta-analyses and large primary studies with unselected samples were given preference for inclusion.</p><p><strong>Results: </strong>Four in ten adults who enter prison meet diagnostic criteria for a drug use disorder, a treatable psychiatric condition often underlying the offences that led to their incarceration. Drug use disorders are approximately ten times more prevalent among people in prison compared with the general population, with a higher excess in women. Comorbid mental disorders are common. Around a third of incarcerated individuals report using drugs during imprisonment, which poses a health and safety risk for people both living and working in prisons. Injecting drug use in prison contributes to blood-borne virus transmission. In addition to its strong link with recidivism, drug use is associated with a markedly increased risk of premature mortality after release from prison, particularly from drug-related causes within the first two weeks post-release. Despite robust evidence supporting the effectiveness of prison-based pharmacological (e.g. opioid agonist treatment) and psychosocial (e.g. therapeutic communities) interventions in reducing drug-related harms, there remains a significant treatment gap within prison settings worldwide. Further research is needed to assess the health benefits of harm reduction services in prisons, including needle and syringe programmes. Strategies to facilitate linkage to and retention in post-release services are key to ensure continuity of care and achieve sustainable treatment outcomes.</p><p><strong>Conclusion: </strong>The high prevalence of drug use and its multiple adverse outcomes among people in prison underscore the need for provision of evidence-based interventions. Expanding and integrating prison-based and post-release interventions to address drug use has the potential to yield both public health and criminal justice benefits.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":"749-764"},"PeriodicalIF":5.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12980310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145562076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motivational smoking cessation counselling and community-based follow-up after hospitalisation for vascular disease: A randomised controlled trial. 血管疾病住院后的动机性戒烟咨询和社区随访:一项随机对照试验
IF 5.3 1区 医学 Q1 PSYCHIATRY Pub Date : 2026-04-01 Epub Date: 2025-11-21 DOI: 10.1111/add.70249
Karin Pleym, Elise Sverre, Harald Weedon-Fekjær, Mohpal Singh Kahlon, Marie Stugaard, Einar Husebye, Serena Tonstad, Toril Dammen, John Munkhaugen
<p><strong>Background and aims: </strong>Evidence for motivational interviewing for smoking cessation is weak, with limited data on long-term abstinence rates. This trial aimed to evaluate the effect of in-hospital motivational interviewing-based smoking cessation counselling combined with proactive referral to community-based follow-up on 6- and 12-month continuous smoking abstinence in patients with atherosclerotic vascular disease.</p><p><strong>Design: </strong>Multicentre, randomised, open-label, blinded-end-point trial with 1:1 randomisation.</p><p><strong>Setting: </strong>Three secondary care hospitals in Norway, with recruitment from November 2021 to October 2023.</p><p><strong>Participants: </strong>Hospitalised patients with established atherosclerotic vascular disease who smoked ≥1 cigarette daily prior to unplanned or elective hospitalisation. A total of 221 were randomised (40% women, mean age 65.2 years), of whom 213 were included in the primary analysis due to 7 deaths and 1 withdrawal.</p><p><strong>Intervention and comparator: </strong>In the intervention group (n = 109), a trained nurse conducted a single 30-minute motivational interviewing-based counselling session, provided a leaflet explaining the local community-based cessation programme, sent discharge information to the general practitioner and arranged for a personal telephone invitation from the centre staff to the follow-up programme. In the control group (n = 111), a physician gave brief cessation advice and the nurse provided a leaflet about the cessation programme and sent discharge information to the general practitioner.</p><p><strong>Measurements: </strong>The primary outcome was self-reported continuous smoking abstinence at 6 months. Secondary outcomes included biochemically validated abstinence (measurement of exhaled carbon monoxide) at 6 months and self-reported abstinence at 12 months. Exploratory outcomes included recurrent vascular events over a median 18-month follow-up.</p><p><strong>Findings: </strong>Smoking abstinence at 6 months was 49.5% (53/107) and 24.5% (26/106) in the intervention and control groups, respectively [odds ratio (OR) = 3.08, 95% confidence interval (CI) = 1.70-5.55, P < 0.001]. The number needed to treat to achieve one additional abstinence was 4 (95% CI = 3-9). Biochemically validated abstinence was 44.9% (48/107) and 20.8% (22/106) in the intervention and control groups, respectively (OR = 3.28, 95% CI = 1.76-6.12). At 12 months, smoking abstinence was 45.7% (48/105) and 27.5% (28/102) in the intervention and control groups, respectively (OR = 2.31, 95% CI = 1.27-4.20). After a median of 18-month follow-up, a prespecified vascular event occurred in 24.8% (27/109) and 34.2% (38/111) of intervention and control participants, respectively.</p><p><strong>Conclusions: </strong>In-hospital motivational counselling combined with proactive referral to follow-up in a community-based cessation programme approximately doubled long-term smok
背景和目的:关于戒烟的动机性访谈的证据不足,关于长期戒烟率的数据有限。本试验旨在评估基于住院动机性访谈的戒烟咨询结合主动转诊到社区随访对动脉粥样硬化性血管疾病患者连续戒烟6个月和12个月的效果。设计:多中心、随机、开放标签、盲终点试验,1:1随机化。环境:挪威的三家二级护理医院,招聘时间为2021年11月至2023年10月。参与者:在非计划或选择性住院前每日吸烟≥1支的确诊动脉粥样硬化性血管疾病的住院患者。共有221人被随机分组(40%为女性,平均年龄65.2岁),其中213人因7人死亡和1人退出而被纳入初步分析。干预和比较:在干预组(n = 109)中,一名训练有素的护士进行了一次30分钟的基于动机性访谈的咨询会议,提供了一份解释当地社区戒烟方案的传单,向全科医生发送出院信息,并安排中心工作人员亲自电话邀请参加后续方案。在对照组(n = 111)中,医生提供简短的戒烟建议,护士提供戒烟计划的传单,并将出院信息发送给全科医生。测量:主要结果是自我报告的6个月持续戒烟情况。次要结果包括6个月时经生化验证的戒断(测量呼出的一氧化碳)和12个月时自我报告的戒断。探索性结果包括在中位18个月随访期间血管复发事件。结果:干预组和对照组在6个月时的戒烟率分别为49.5%(53/107)和24.5%(26/106),[优势比(OR) = 3.08, 95%可信区间(CI) = 1.70-5.55, P]结论:在以社区为基础的戒烟计划中,住院动机咨询结合主动转诊随访,约使动脉粥样硬化性血管疾病患者的长期戒烟率翻了一番,并减少了新的血管事件的发生。
{"title":"Motivational smoking cessation counselling and community-based follow-up after hospitalisation for vascular disease: A randomised controlled trial.","authors":"Karin Pleym, Elise Sverre, Harald Weedon-Fekjær, Mohpal Singh Kahlon, Marie Stugaard, Einar Husebye, Serena Tonstad, Toril Dammen, John Munkhaugen","doi":"10.1111/add.70249","DOIUrl":"10.1111/add.70249","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background and aims: &lt;/strong&gt;Evidence for motivational interviewing for smoking cessation is weak, with limited data on long-term abstinence rates. This trial aimed to evaluate the effect of in-hospital motivational interviewing-based smoking cessation counselling combined with proactive referral to community-based follow-up on 6- and 12-month continuous smoking abstinence in patients with atherosclerotic vascular disease.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Multicentre, randomised, open-label, blinded-end-point trial with 1:1 randomisation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;Three secondary care hospitals in Norway, with recruitment from November 2021 to October 2023.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants: &lt;/strong&gt;Hospitalised patients with established atherosclerotic vascular disease who smoked ≥1 cigarette daily prior to unplanned or elective hospitalisation. A total of 221 were randomised (40% women, mean age 65.2 years), of whom 213 were included in the primary analysis due to 7 deaths and 1 withdrawal.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Intervention and comparator: &lt;/strong&gt;In the intervention group (n = 109), a trained nurse conducted a single 30-minute motivational interviewing-based counselling session, provided a leaflet explaining the local community-based cessation programme, sent discharge information to the general practitioner and arranged for a personal telephone invitation from the centre staff to the follow-up programme. In the control group (n = 111), a physician gave brief cessation advice and the nurse provided a leaflet about the cessation programme and sent discharge information to the general practitioner.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Measurements: &lt;/strong&gt;The primary outcome was self-reported continuous smoking abstinence at 6 months. Secondary outcomes included biochemically validated abstinence (measurement of exhaled carbon monoxide) at 6 months and self-reported abstinence at 12 months. Exploratory outcomes included recurrent vascular events over a median 18-month follow-up.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;Smoking abstinence at 6 months was 49.5% (53/107) and 24.5% (26/106) in the intervention and control groups, respectively [odds ratio (OR) = 3.08, 95% confidence interval (CI) = 1.70-5.55, P &lt; 0.001]. The number needed to treat to achieve one additional abstinence was 4 (95% CI = 3-9). Biochemically validated abstinence was 44.9% (48/107) and 20.8% (22/106) in the intervention and control groups, respectively (OR = 3.28, 95% CI = 1.76-6.12). At 12 months, smoking abstinence was 45.7% (48/105) and 27.5% (28/102) in the intervention and control groups, respectively (OR = 2.31, 95% CI = 1.27-4.20). After a median of 18-month follow-up, a prespecified vascular event occurred in 24.8% (27/109) and 34.2% (38/111) of intervention and control participants, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In-hospital motivational counselling combined with proactive referral to follow-up in a community-based cessation programme approximately doubled long-term smok","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":"957-969"},"PeriodicalIF":5.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12980294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145562061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Divergent Phosphorus-Mining Strategies in Simple and Compound Cluster Roots in Extremely Phosphorus-Impoverished Soils in Southwest Australia. 澳大利亚西南部极度缺磷土壤中简单根系和复合根系的不同采磷策略
IF 6.3 1区 生物学 Q1 PLANT SCIENCES Pub Date : 2026-04-01 Epub Date: 2025-12-21 DOI: 10.1111/pce.70334
Hirotsuna Yamada, Clément E Gille, Pallavi, Li Yan, Gareth Nealon, Jun Wasaki, Erik J Veneklaas, Hans Lambers

Most Proteaceae and some Fabaceae species produce specialised cluster roots (CRs), and are abundant in severely phosphorus (P)-impoverished soils in southwest Australia. Two types of CRs, compound and simple, have been identified. However, the difference in their P-mining strategies remains unclear. Therefore, we conducted glasshouse and field experiments to compare the P-acquisition strategies among 18 CR-producing species in Proteaceae and Fabaceae. Proteaceae produced a significantly larger mass of CRs than Fabaceae. Particularly, Banksia species produced the largest mass of compound CRs and exhibited the greatest net plant-absorbed P in pots and consistently higher mature leaf manganese concentration in the field. In contrast, Hakea and Grevillea species produced less mass of simple CRs but three times as much soil adhered to their CRs per CR dry weight, resulting in greater absorbed P per CR weight. All plants depleted similar P compounds from soil and accessed c. 52% of P that was not extracted by a NaOH-EDTA solution, suggesting that both CRs shared a common physiological function for mining scarcely available P. This study highlights two divergent P-acquisition strategies: greater biomass investment in compound CRs versus greater P-acquisition efficiency in simple CRs.

大多数变形科和一些豆科物种产生特殊的簇状根(CRs),在澳大利亚西南部严重缺磷(P)的土壤中丰富。已鉴定出两种类型的cr,化合物和简单的。然而,他们在p开采策略上的差异仍不清楚。为此,我们通过温室和田间试验,比较了变形科和豆科18种产铬植物的p获取策略。变形科产生的CRs质量显著高于豆科。其中,Banksia品种复合cr含量最高,盆栽净吸收P含量最高,田间成熟叶锰浓度持续较高。相比之下,Hakea和Grevillea品种产生的简单CR质量较少,但每CR干重其CR上的土壤粘附量是其3倍,导致每CR重吸收的P更高。所有植物都从土壤中消耗了相似的磷化合物,并获得了未被NaOH-EDTA溶液提取的0.52%的磷,这表明两种cr都具有开采稀缺磷的共同生理功能。该研究强调了两种不同的P获取策略:复合cr的生物量投资更高,而简单cr的P获取效率更高。
{"title":"Divergent Phosphorus-Mining Strategies in Simple and Compound Cluster Roots in Extremely Phosphorus-Impoverished Soils in Southwest Australia.","authors":"Hirotsuna Yamada, Clément E Gille, Pallavi, Li Yan, Gareth Nealon, Jun Wasaki, Erik J Veneklaas, Hans Lambers","doi":"10.1111/pce.70334","DOIUrl":"10.1111/pce.70334","url":null,"abstract":"<p><p>Most Proteaceae and some Fabaceae species produce specialised cluster roots (CRs), and are abundant in severely phosphorus (P)-impoverished soils in southwest Australia. Two types of CRs, compound and simple, have been identified. However, the difference in their P-mining strategies remains unclear. Therefore, we conducted glasshouse and field experiments to compare the P-acquisition strategies among 18 CR-producing species in Proteaceae and Fabaceae. Proteaceae produced a significantly larger mass of CRs than Fabaceae. Particularly, Banksia species produced the largest mass of compound CRs and exhibited the greatest net plant-absorbed P in pots and consistently higher mature leaf manganese concentration in the field. In contrast, Hakea and Grevillea species produced less mass of simple CRs but three times as much soil adhered to their CRs per CR dry weight, resulting in greater absorbed P per CR weight. All plants depleted similar P compounds from soil and accessed c. 52% of P that was not extracted by a NaOH-EDTA solution, suggesting that both CRs shared a common physiological function for mining scarcely available P. This study highlights two divergent P-acquisition strategies: greater biomass investment in compound CRs versus greater P-acquisition efficiency in simple CRs.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"1833-1847"},"PeriodicalIF":6.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12976584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145802787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protoplast-Based Functional Genomics and Genome Editing: Progress, Challenges and Applications. 基于原生质体的功能基因组学和基因组编辑:进展、挑战和应用。
IF 6.3 1区 生物学 Q1 PLANT SCIENCES Pub Date : 2026-04-01 Epub Date: 2026-01-11 DOI: 10.1111/pce.70375
Jo-Wei Allison Hsieh, Fu-Hui Wu, Dian-Xuan Yang, Ai-En Wu, Ching-Ann Liu, Chang-Hung Chen, Shinn-Zong Lin, Ying-Chung Jimmy Lin, Choun-Sea Lin

Protoplast-based systems provide a powerful and versatile platform for exploring how plants sense and respond to their environment. By enabling the direct delivery of proteins, DNA, and RNA into plant cells after cell wall removal, this approach facilitates precise molecular dissection of signaling, stress adaptation, and gene regulation across both model species and economically important crops. In this review, we analyzed 1050 published articles and categorizing them by delivery methods, research focus, plant species, and tissue types. We further highlight recent advances, including the application of single-cell transcriptomics, which provides unprecedented resolution for dissecting cellular responses and offers deeper insights into the mechanisms underlying stress resilience. Importantly, protoplast regeneration is gaining renewed attention not only as a model system for studying cellular reprogramming but also as a practical platform for crop improvement. Applications of protoplast regeneration include protoplast fusion, which integrates nuclear and organellar DNA/genomes from divergent parents to accelerate breeding and enhance tolerance to both biotic and abiotic stresses. Another important application is CRISPR/Cas ribonucleoprotein (RNP)-based editing targeting stress-resilience-related genes. In asexually propagated or highly heterozygous perennial crops with limited sexual reproduction, protoplast-based RNP delivery offers a viable and regulation-compliant strategy. This approach may help address public concerns over transgenic technologies while enabling the rapid development of stress-tolerant cultivars.

原生质体系统为探索植物如何感知和响应环境提供了一个强大而通用的平台。通过在细胞壁去除后将蛋白质、DNA和RNA直接传递到植物细胞中,这种方法有助于对模式物种和重要经济作物的信号、胁迫适应和基因调控进行精确的分子解剖。本文对已发表的1050篇论文进行了分析,并按发表方式、研究重点、植物种类和组织类型进行了分类。我们进一步强调了最近的进展,包括单细胞转录组学的应用,它为解剖细胞反应提供了前所未有的分辨率,并为应激恢复的潜在机制提供了更深入的见解。重要的是,原生质体再生不仅作为研究细胞重编程的模型系统,而且作为作物改良的实用平台而重新受到关注。原生质体再生的应用包括原生质体融合,它将来自不同亲本的细胞核和细胞器DNA/基因组整合在一起,以加速育种,增强对生物和非生物胁迫的耐受性。另一个重要的应用是基于CRISPR/Cas核糖核蛋白(RNP)的靶向应激恢复相关基因的编辑。在有性繁殖有限的无性繁殖或高度杂合的多年生作物中,基于原生质体的RNP传递提供了一种可行且符合法规的策略。这种方法可能有助于解决公众对转基因技术的担忧,同时使抗逆性品种的快速发展成为可能。
{"title":"Protoplast-Based Functional Genomics and Genome Editing: Progress, Challenges and Applications.","authors":"Jo-Wei Allison Hsieh, Fu-Hui Wu, Dian-Xuan Yang, Ai-En Wu, Ching-Ann Liu, Chang-Hung Chen, Shinn-Zong Lin, Ying-Chung Jimmy Lin, Choun-Sea Lin","doi":"10.1111/pce.70375","DOIUrl":"10.1111/pce.70375","url":null,"abstract":"<p><p>Protoplast-based systems provide a powerful and versatile platform for exploring how plants sense and respond to their environment. By enabling the direct delivery of proteins, DNA, and RNA into plant cells after cell wall removal, this approach facilitates precise molecular dissection of signaling, stress adaptation, and gene regulation across both model species and economically important crops. In this review, we analyzed 1050 published articles and categorizing them by delivery methods, research focus, plant species, and tissue types. We further highlight recent advances, including the application of single-cell transcriptomics, which provides unprecedented resolution for dissecting cellular responses and offers deeper insights into the mechanisms underlying stress resilience. Importantly, protoplast regeneration is gaining renewed attention not only as a model system for studying cellular reprogramming but also as a practical platform for crop improvement. Applications of protoplast regeneration include protoplast fusion, which integrates nuclear and organellar DNA/genomes from divergent parents to accelerate breeding and enhance tolerance to both biotic and abiotic stresses. Another important application is CRISPR/Cas ribonucleoprotein (RNP)-based editing targeting stress-resilience-related genes. In asexually propagated or highly heterozygous perennial crops with limited sexual reproduction, protoplast-based RNP delivery offers a viable and regulation-compliant strategy. This approach may help address public concerns over transgenic technologies while enabling the rapid development of stress-tolerant cultivars.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"2183-2199"},"PeriodicalIF":6.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12976588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1